首页> 外文OA文献 >Physicochemical Stability and Compatibility of Long-Acting Muscarinic Antagonist Revefenacin Inhalation Solution and Inhaled Corticosteroid Budesonide Inhalation Suspension

【2h】

Physicochemical Stability and Compatibility of Long-Acting Muscarinic Antagonist Revefenacin Inhalation Solution and Inhaled Corticosteroid Budesonide Inhalation Suspension

机译：长效毒蕈碱拮抗剂revefenacin吸入溶液和吸入皮质类固醇的稳定性和兼容性的兼容性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
J. Zhang; C. Ooi; L. Cochran; K. Ngim;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Long-acting muscarinic antagonist plus long-acting beta agonist versus long-acting beta agonist plus inhaled corticosteroid for COPD: A systematic review and meta-analysis [J] . Horita Nobuyuki, Miyazawa Naoki, Tomaru Koji, Respirology : . 2015,第8期

机译：长效毒蕈碱拮抗剂加长效β激动剂与长效β激动剂加吸入性糖皮质激素治疗COPD：系统评价和荟萃分析
2. Long-Acting beta-Agonists (LABA) Combined With Long-Acting Muscarinic Antagonists or LABA Combined With Inhaled Corticosteroids for Patients With Stable COPD [J] . Horita Nobuyuki, Nagashima Akimichi, Kaneko Takeshi JAMA: the Journal of the American Medical Association . 2017,第13期

机译：长效β-激动剂（Laba）与长效的毒蕈碱拮抗剂或Laba联合与吸入的皮质类固醇相结合，用于稳定COPD的患者
3. Cost Effectiveness of the Long-Acting P2-Adrenergic Agonist (L ABA)/Long-Acting Muscarinic Antagonist Dual Bronchodilator Indacaterol/Glycopyrronium Versus the LAB A/Inhaled Corticosteroid Combination Salmeterol/Fluticasone in Patients with Chronic Obstructive Pulmonary Disease: Analyses Conducted for Canada, France, Italy, and Portugal [J] . M. Reza Maleki-Yazdi, Mathieu Molimard, Dorothy L. Keininger, Applied health economics and health policy . 2016,第5期

机译：长效P2-肾上腺素激动剂（L ABA）/长效毒蕈碱拮抗药双重支气管扩张药Indacaterol / Glycopyrronium与LAB A /吸入糖皮质激素联合沙美特罗/氟替卡松在慢性阻塞性肺部疾病患者中的成本效益比较：分析法国，意大利和葡萄牙
4. THE EFFECT OF CARRIER PARTICLE SIZE ON ADHESION, CONTENT UNIFORMITY AND INHALATION PERFORMANCE OF BUDESONIDE USING DRY POWDER INHALERS [C] . W. Kaialy, H. Larhrib, A. Nokhodchi UK-China Particle Technology Forum . 2012

机译：使用干粉吸入器对载体粒径对粘附，含量均匀性和吸入性能的影响
5. Addition of leukotriene receptor antagonists versus long acting beta agonists to inhaled corticosteroid therapy for asthma treatment in older adults: A retrospective data analysis of effectiveness, safety and cost. [D] . Altawalbeh, Shoroq Mahmoud. 2015

机译：在吸入性糖皮质激素治疗中，将白三烯受体拮抗剂与长效β激动剂相比，用于老年人的哮喘治疗：有效性，安全性和成本的回顾性数据分析。
6. Once daily Long‐acting beta2‐agonists/Inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic antagonists for people with chronic obstructive pulmonary disease [O] . Agnieszka Sliwka, Milosz Jankowski, Iwona Gross‐Sondej, -1

机译：每天一次对于患有慢性阻塞性肺疾病的人长效β2受体激动剂/吸入皮质类固醇联合吸入器与吸入长效毒蕈碱拮抗剂合用
7. Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease [O] . Agnieszka Sliwka, Milosz Jankowski, Iwona Gross-Sondej, 2018

机译：曾经每日长效的β-β-激动剂/吸入皮质类固醇组合吸入器与慢性阻塞性肺病的人类吸入的长效肌肉蛋白拮抗剂

Physicochemical Stability and Compatibility of Long-Acting Muscarinic Antagonist Revefenacin Inhalation Solution and Inhaled Corticosteroid Budesonide Inhalation Suspension

著录项

引文网络

相似文献

相关主题

期刊订阅